MARKET PULSE-MannKind, Apollo Education, America Movil, GlaxoSmithKline
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were mostly flat on Wednesday. Dow Jones industrial average futures were unchanged at 0, S&P 500 futures were up 0.11 percent at 1,879.9 and Nasdaq 100 futures were up 0.29 percent at 3,660.75.
** MANNKIND CORP, Tuesday close $4.02, +95.27 pct premarket
U.S. health advisers on Tuesday recommended approval of the company's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with traditional insulin therapy.
** APOLLO EDUCATION GROUP, Tuesday close $35.16, -3.30 pct premarket
The company reported lower-than-expected quarterly revenue as enrollments declined 16.8 percent at its flagship University of Phoenix.
The company also said it had received a subpoena from the U.S. Department of Education's Office of Inspector General, seeking information about the operations of the Northeast region of the University of Phoenix.